Article Information
History
- April 29, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Gabriel Birgand, PhD1,2,*,
- Nico T. Mutters, MD3,
- Jonathan Otter, PhD1,
- Vanessa M. Eichel, MD3,
- Didier Lepelletier, MD2,
- Daniel J. Morgan, MD4 and
- Jean-Christophe Lucet, MD5,6
- 1NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London, Hammersmith Campus, Du Cane Road, London, UK
- 2Centre Hospitalier Universitaire de Nantes, Nantes, France
- 3Heidelberg University Hospital, Centre for Infectious Diseases, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany
- 4University of Maryland School of Medicine, VA Maryland Healthcare System, Baltimore
- 5INSERM, IAME, UMR 1137, F-75018 Paris, France; Univ Paris Diderot, Sorbonne Paris Cité, F-75018 Paris, France
- 6AP-HP, Hôpital Bichat – Claude Bernard, Infection Control Unit, F-75018 Paris, France
- ↵* Corresponding author; email: g.birgand{at}imperial.ac.uk
Posted April 29, 2020.
Analysis of national and international guidelines on respiratory protection equipment for COVID-19 in healthcare settings
